Eun-Jin Kim

Dr. Eun-Jin Kim

Korea Disease Control and Prevention Agency, Cheongju-si, Republic of Korea

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JLJi Joo Lee
Ji Joo Lee
YCYoung June Choe
Young June Choe
HJHyeongseop Jeong
Hyeongseop Jeong
MKMoonsu Kim
Moonsu Kim
SKSeonggon Kim
Seonggon Kim
YPYoung-Joon Park
Young-Joon Park
Lee JJ, et al. J Korean Med Sci. 2021 Dec;36(50):e346. https://doi.org/10.3346/jkms.2021.36.e346

3 July 2014 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
HYHyeon-Jong Yang
Hyeon-Jong Yang
SLSo-Yeon Lee
So-Yeon Lee
DSDong In Suh
Dong In Suh
YSYoun Ho Shin
Youn Ho Shin
BKByoung-Ju Kim
Byoung-Ju Kim
SHSoo-Jong Hong
Soo-Jong Hong
This paper describes the background, aim, and design of a prospective birth-cohort study in Korea called the COhort for Childhood Origin of Asthma and allergic diseases (COCOA). COCOA objectives are to investigate the individual and interactive effects of genetics, perinatal environment, maternal lifestyle, and psychosocial stress of mother and child on pediatric susceptibility to allergic diseases. The participants in COCOA represents a Korean inner-city population. Recruitment started on 19 November, 2007 and will continue until 31 December, 2015. Recruitment is performed at five medical centers and eight public-health centers for antenatal care located in Seoul. Participating mother-baby pairs are followed from before birth to adolescents. COCOA investigates whether the following five environmental variables contribute causally to the development and natural course of allergic diseases: (1) perinatal indoor factors (i.e. house-dust mite, bacterial endotoxin, tobacco smoking, and particulate matters 2.5 and 10), (2) perinatal outdoor pollutants, (3) maternal prenatal psychosocial stress and the child’s neurodevelopment, (4) perinatal nutrition, and (5) perinatal microbiome. Cord blood and blood samples from the child are used to assess whether the child’s genes and epigenetic changes influence allergic-disease susceptibility. Thus, COCOA aims to investigate the contributions of genetics, epigenetics, and various environmental factors in early life to allergic-disease susceptibility in later life. How these variables interact to shape allergic-disease susceptibility is also a key aim. The COCOA data collection schedule includes 11 routine standardized follow-up assessments of all children at 6 months and every year until 10 years of age, regardless of allergic-disease development. The mothers will complete multiple questionnaires to assess the baseline characteristics, the child’s exposure to environmental factors, maternal pre- and post-natal psychological stress, and the child’s neurodevelopment, nutritional status, and development of allergic and respiratory illnesses. The child’s microbiome, genes, epigenetics, plasma cytokine levels, and neuropsychological status, the microbiome of the residence, and the levels of indoor and outdoor pollutants are measured by standard procedures. The COCOA study will improve our understanding of how individual genetic or environmental risk factors influence susceptibility to allergic disease and how these variables interact to shape the phenotype of allergic diseases.

18 August 2021 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
PDF file
HKHeui Man Kim
Heui Man Kim
ELEun Jung Lee
Eun Jung Lee
NLNam‐Joo Lee
Nam‐Joo Lee
SWSang Hee Woo
Sang Hee Woo
JKJeong-Min Kim
Jeong-Min Kim
EKEun-Jin Kim
Eun-Jin Kim
Background: After the detection of the first case of coronavirus disease 2019 (COVID‐19) in South Korea on January 20, 2019, it has triggered three major outbreaks. To decrease the disease burden of COVID‐19, social distancing and active mask wearing were encouraged, reducing the number of patients with influenza‐like illness and altering the detection rate of influenza and respiratory viruses in the Korea Influenza and Respiratory Viruses Surveillance System (KINRESS). We examined the changes in respiratory viruses due to COVID‐19 in South Korea and virological causes of the high detection rate of human rhinovirus (hRV) in 2020.Methods: We collected 52 684 oropharyngeal or nasopharyngeal swab samples from patients with influenza‐like illness in cooperation with KINRESS from 2016 to 2020. Influenza virus and other respiratory viruses were confirmed using real‐time RT‐PCR. The weekly detection rate was used to compare virus detection patterns.Results: Non‐enveloped virus (hRV, human bocavirus, and human adenovirus) detection rates during the COVID‐19 pandemic were maintained. The detection rate of hRV significantly increased in 2020 compared with that in 2019 and was negatively correlated with number of COVID‐19‐confirmed cases in 2020. The distribution of strains and genetic characteristics in hRV did not differ between 2019 and 2020.Conclusions: The COVID‐19 pandemic impacted the respiratory virus detection rate. The extremely low detection rate of enveloped viruses resulted from efforts to prevent the spread of COVID‐19 in South Korea. The high detection rate of hRV may be related to resistance against environmental conditions as a non‐enveloped virus and the long period of viral shedding from patients.

1 January 2024 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HCHyo Jin Cho
Hyo Jin Cho
JRJee Eun Rhee
Jee Eun Rhee
DKDayun Kang
Dayun Kang
ECEun Young Cho
Eun Young Cho
NLNam-Joo Lee
Nam-Joo Lee
KYKi Wook Yun
Ki Wook Yun
Cho HJ, et al. J Korean Med Sci. 2024 May;39(19):e171. https://doi.org/10.3346/jkms.2024.39.e171

23 July 2024 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
NLNam-Joo Lee
Nam-Joo Lee
SWSangHee Woo
SangHee Woo
JRJee Eun Rhee
Jee Eun Rhee
JLJaehee Lee
Jaehee Lee
SLSangwon Lee
Sangwon Lee
EKEun-Jin Kim
Eun-Jin Kim
Nam-Joo Lee, M.S., SangHee Woo, M.S., Jee Eun Rhee, Ph.D., Jaehee Lee, M.S., Sangwon Lee, Ph.D., and Eun-Jin Kim, Ph.D.. Ann Lab Med -0001;0:. https://doi.org/10.3343/alm.2023.0484

28 February 2021 in Osong Public Health and Research Perspectives
Verified
Journal Article
Open access
APAe Kyung Park
Ae Kyung Park
IKIl-Hwan Kim
Il-Hwan Kim
JKJunyoung Kim
Junyoung Kim
JKJeong-Min Kim
Jeong-Min Kim
HKHeui Man Kim
Heui Man Kim
EKEun-Jin Kim
Eun-Jin Kim
Since a novel beta-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019, there has been a rapid global spread of the virus. Genomic surveillance was conducted on samples isolated from infected individuals to monitor the spread of genetic variants of SARS-CoV-2 in Korea. The Korea Disease Control and Prevention Agency performed whole genome sequencing of SARS-CoV-2 in Korea for 1 year (January 2020 to January 2021). A total of 2,488 SARS-CoV-2 cases were sequenced (including 648 cases from abroad). Initially, the prevalent clades of SARS-CoV-2 were the S and V clades, however, by March 2020, GH clade was the most dominant. Only international travelers were identified as having G or GR clades, and since the first variant 501Y.V1 was identified (from a traveler from the United Kingdom on December 22nd, 2020), a total of 27 variants of 501Y.V1, 501Y.V2, and 484K.V2 have been classified (as of January 25th, 2021). The results in this study indicated that quarantining of travelers entering Korea successfully prevented dissemination of the SARS-CoV-2 variants in Korea.